Impact of a health communication intervention to improve glaucoma treatment adherence: Results of the interactive study to increase glaucoma adherence to treatment trial

Archives of Ophthalmology

Volumn 130, Issue 10, 2012, Pages 1252-1258

  Glanz, Karen ^a   Beck, Allen D ^b   Bundy, Lucja ^b   Primo, Susan ^b   Lynn, Michael J ^b   Cleveland, Julia ^b   Wold, Jessica A ^b   Echt, Katharina V ^b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT;

ADULT; AGED; ARTICLE; AUTOMATION; CONTROLLED STUDY; FEMALE; GLAUCOMA; HEALTH COMMUNICATION INTERVENTION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MEDICAL RECORD; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TELEMEDICINE; TELEPHONE; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; APPOINTMENTS AND SCHEDULES; DRUG PRESCRIPTIONS; FEMALE; GLAUCOMA; HEALTH BEHAVIOR; HEALTH COMMUNICATION; HEALTH PROMOTION; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION AS TOPIC; TEACHING MATERIALS; TELEPHONE; YOUNG ADULT;

EID: 84867340542     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2012.1607     Document Type: Article

References (36)

1. Prevent Blindness America website. http://www.preventblindness.org. Accessed April 1, 2012.
2. Rudnicka AR, Mt-Isa S, Owen CG, Cook DG, Ashby D. Variations in primary open-angle glaucoma prevalence by age, gender, and race: a Bayesian meta-analysis. Invest Ophthalmol Vis Sci. 2006;47(10):4254-4261. (Pubitemid 46579346)
3. McGwin G, Khoury R, Cross J, Owsley C. Vision impairment and eye care utilization among Americans 50 and older. Curr Eye Res. 2010;35(6):451-458.
4. Lee PP, Walt JG, Doyle JJ, et al. A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma. Arch Ophthalmol. 2006;124(1):12-19. (Pubitemid 43063883)
5. Varma R, Lee PP, Goldberg I, Kotak S. An assessment of the health and economic burdens of glaucoma. Am J Ophthalmol. 2011;152(4):515-522.
6. Ramulu PY, West SK, Munoz B, Jampel HD, Friedman DS. Driving cessation and driving limitation in glaucoma: the Salisbury Eye Evaluation Project. Ophthalmology. 2009;116(10):1846-1853.
7. Ramulu PY, West SK, Munoz B, Jampel HD, Friedman DS. Glaucoma and reading speed: the Salisbury Eye Evaluation project. Arch Ophthalmol. 2009;127(1):82-87.
8. Gutierrez P, Wilson MR, Johnson C, et al. Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol. 1997;115(6):777-784. (Pubitemid 27276261)
9. Rees G, Leong O, Crowston JG, Lamoureux EL. Intentional and unintentional non-adherence to ocular hypotensive treatment in patients with glaucoma. Ophthalmology. 2010;117(5):903-908.
10. Sleath B, Ballinger R, Covert D, Robin AL, Byrd JE, Tudor G. Self-reported prevalence and factors associated with nonadherence with glaucoma medications in veteran outpatients. Am J Geriatr Pharmacother. 2009;7(2):67-73.
11. Rossi GC, Pasinetti GM, Scudeller L, Tinelli C, Milano G, Bianchi PE. Monitoring adherence rates in glaucoma patients using the Travatan Dosing Aid: a 6-month study comparing patients on travoprost 0.004% and patients on travoprost 0.004%/timolol 0.5% fixed combination. Expert Opin Pharmacother. 2010;11(4):499-504.
12. Nordmann JP, Baudouin C, Renard JP, et al. Measurement of treatment compliance using a medical device for glaucoma patients associated with intraocular pressure control: a survey. Clin Ophthalmol. 2010;4:731-739.
13. Shaya FT. Compliance with medicine. Ophthalmol Clin North Am. 2005;18(4):611-617. (Pubitemid 41728027)
14. Gwira JA, Vistamehr S, Shelsta H, et al. Factors associated with failure to follow up after glaucoma screening: a study in an African American population. Ophthalmology. 2006;113(8):1315-1319.
15. Kosoko O, Quigley HA, Vitale S, Enger C, Kerrigan L, Tielsch JM. Risk factors for noncompliance with glaucoma follow-up visits in a residents' eye clinic. Ophthalmology. 1998;105(11):2105-2111. (Pubitemid 30211781)
16. Murakami Y, Lee BW, Duncan M, et al. Racial and ethnic disparities in adherence to glaucoma follow-up visits in a county hospital population. Arch Ophthalmol. 2011;129(7):872-878.
17. Centers for Disease Control and Prevention (CDC). Eye-care utilization among women aged >or =40 years with eye diseases - 19 states, 2006-2008. MMWR Morb Mortal Wkly Rep. 2010;59(19):588-591.
18. Tsai JC, McClure CA, Ramos SE, Schlundt DG, Pichert JW. Compliance barriers in glaucoma: a systematic classification. J Glaucoma. 2003;12(5):393-398. (Pubitemid 37237370)
19. Stryker JE, Beck AD, Primo SA, et al. An exploratory study of factors influencing glaucoma treatment adherence. J Glaucoma. 2010;19(1):66-72.
20. Kowing D, Messer D, Slagle S, Wasik A; V-POAG Study Group. Programs to optimize adherence in glaucoma. Optometry. 2010;81(7):339-350.
21. Gray TA, Orton LC, Henson D, Harper R, Waterman H. Interventions for improving adherence to ocular hypotensive therapy. Cochrane Database Syst Rev. 2009;(2):CD006132.
22. Okeke CO, Quigley HA, Jampel HD, et al. Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients. Ophthalmology. 2009;116(12):2286-2293.
23. Borenstein MT, Rothstein H, Cohen J, Schoenfeld D. Power and Precision, Version 2: A Computer Program for Statistical Power Analysis and Confidence Intervals. Englewood, NJ: Biostat Inc; 2001.
24. Sleath B, Robin AL, Covert D, Byrd JE, Tudor G, Svarstad B. Patient-reported behavior and problems in using glaucoma medications. Ophthalmology. 2006;113(3):431-436.
25. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73(1):13-32. doi:10.1093/biomet/73.1.13.
26. Kass MA, Meltzer DW, Gordon M, Cooper D, Goldberg J. Compliance with topical pilocarpine treatment. Am J Ophthalmol. 1986;101(5):515-523. (Pubitemid 16114195)
27. Kass MA, Gordon M, Morley RE Jr, Meltzer DW, Goldberg JJ. Compliance with topical timolol treatment. Am J Ophthalmol. 1987;103(2):188-193. (Pubitemid 17005483)
28. Olthoff CM, Schouten JS, van de Borne BW, Webers CA. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review. Ophthalmology. 2005;112(6):953-961. (Pubitemid 40797446)
29. Juzych MS, Randhawa S, Shukairy A, Kaushal P, Gupta A, Shalauta N. Functional health literacy in patients with glaucoma in urban settings. Arch Ophthalmol. 2008;126(5):718-724. (Pubitemid 351679570)
30. Friedman DS, Okeke CO, Jampel HD, et al. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma. Ophthalmology. 2009;116(6):1097-1105.
31. Tsai JC. Medication adherence in glaucoma: approaches for optimizing patient compliance. Curr Opin Ophthalmol. 2006;17(2):190-195. (Pubitemid 43790816)
32. Quigley HA, Friedman DS, Hahn SR. Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study. Ophthalmology. 2007;114(9):1599-1606. (Pubitemid 47332674)
33. Adams WG, Fuhlbrigge AL, Miller CW, et al. TLC-Asthma: an integrated information system for patient-centered monitoring, case management, and point-of-care decision support. AMIA Annu Symp Proc. 2003;2003:1-5.
34. Armstrong AW, Watson AJ, Makredes M, Frangos JE, Kimball AB, Kvedar JC. Text-message reminders to improve sunscreen use: a randomized, controlled trial using electronic monitoring. Arch Dermatol. 2009;145(11):1230-1236.
35. Rimer BK, Halabi S, Sugg Skinner C, et al. Effects of a mammography decision-making intervention at 12 and 24 months. Am J Prev Med. 2002;22(4):247-257. (Pubitemid 34436891)
36. Lauver DR, Settersten L, Kane JH, Henriques JB. Tailored messages, external barriers, and women's utilization of professional breast cancer screening over time. Cancer. 2003;97(11):2724-2735. (Pubitemid 36605139)